These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 18839171

  • 1. Simultaneous appearance of methotrexate-associated lymphoproliferative disorder and tuberculous meningitis demonstrating the definitive role of immunosuppression.
    Nagai S, Izutsu K, Watanabe T, Kurokawa M.
    Ann Hematol; 2009 Jun; 88(6):589-90. PubMed ID: 18839171
    [No Abstract] [Full Text] [Related]

  • 2. Complications of immunosuppression associated with weekly low dose methotrexate.
    Shiroky JB, Frost A, Skelton JD, Haegert DG, Newkirk MM, Neville C.
    J Rheumatol; 1991 Aug; 18(8):1172-5. PubMed ID: 1941818
    [Abstract] [Full Text] [Related]

  • 3. Methotrexate-related lymphoproliferative disorder with extensive vascular involvement in a patient with rheumatoid arthritis.
    Shimura C, Satoh T, Takayama K, Yokozeki H.
    J Am Acad Dermatol; 2009 Jul; 61(1):126-9. PubMed ID: 19539849
    [Abstract] [Full Text] [Related]

  • 4. Methotrexate-associated lymphoproliferative disorder in a patient with rheumatoid arthritis presenting in the skin.
    Clarke LE, Junkins-Hopkins J, Seykora JT, Adler DJ, Elenitsas R.
    J Am Acad Dermatol; 2007 Apr; 56(4):686-90. PubMed ID: 17141365
    [Abstract] [Full Text] [Related]

  • 5. Methotrexate-associated lymphoproliferative disorder mimicking pyocyanic ecthyma gangrenosum in a patient with rheumatoid arthritis.
    Inuzuka K, Endo Y, Kato M, Fujisawa A, Tanioka M, Kabashima K, Tsukamoto H, Sonobe J, Bessho K, Miyachi Y.
    Eur J Dermatol; 2013 Apr; 23(3):418-9. PubMed ID: 23783770
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Arthrorheumatism with methotrexate-associated lymphoproliferative disorder in the brain.
    Tamura R, Nakamura Y, Kuroshima Y.
    J Neurosurg Sci; 2016 Sep; 60(3):400-401. PubMed ID: 28097831
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Polyradiculopathy due to methotrexate-induced ebv-associated lymphoproliferative disorder.
    Kumar N, Sandroni P, Steensma DP, Luthra HS, Habermann TM.
    Neurology; 2008 Nov 11; 71(20):1644-5. PubMed ID: 19001256
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Choledochoduodenal Fistula during Chemotherapy with Brentuximab Vedotin for Methotrexate-associated Lymphoproliferative Disorder.
    Eso Y, Uza N, Shirakawa K, Sawada K, Katsuragi K, Matsuura M, Seno H.
    Intern Med; 2018 Aug 01; 57(15):2203-2207. PubMed ID: 29526961
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Methotrexate-associated lymphoproliferative disorder presenting as giant ulcers on the leg.
    Oka T, Miyagaki T, Nakamura R, Funamizu K, Sugaya M, Ebisawa K, Koya J, Kurokawa M, Sato S.
    Clin Exp Dermatol; 2018 Dec 01; 43(8):930-933. PubMed ID: 29855057
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.